Siddhartha Ganguly, MD, FACP

Carol Cockrell Curran Distinguished Centennial Chief in Hematologic Oncology, Dr. Mary and Ron Neal Cancer Center
Professor of Clinical Oncology, Academic Institute
Full Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Ganguly is a board-certified hematologist specializing in the clinical care and research of hematological malignancies, cellular therapeutics, and bone marrow transplantation. Dr. Ganguly was a A. Drue Jennings endowed professor of medical oncology at the University of Kansas Cancer Center in Westwood, Kansas where he was also the Deputy Director of the Division of Hematological Malignancies and Cellular Therapeutics, the Associate Director of Blood and Marrow Transplantation Program, and the Director of Lymphoma and Myeloma Program.

Dr. Ganguly received his undergraduate degree from Calcutta Medical College and his medical degree from the Department of Internal Medicine, Post Graduate, Institute of Medical Education and Research in India. Additionally, he completed his residency in internal medicine and fellowship in hematology at Baylor College of Medicine and concluded another fellowship in bone marrow transplantation at Baylor College of Medicine, Center for Cell and Gene Therapy.

Publications

Functional characterization of NPM1–TYK2 fusion oncogene
Kuravi, S, Baker, RW, Mushtaq, MU, Saadi, I, Lin, TL, Vivian, CJ, Valluripalli, A, Abhyankar, S, Ganguly, S, Cui, W, Elenitoba-Johnson, KSJ, Welch, DR, Jensen, RA, Saunthararajah, Y, McGuirk, JP & Balusu, R 2022, , npj Precision Oncology, vol. 6, no. 1, 3. https://doi.org/10.1038/s41698-021-00246-4

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
Murthy, HS, Ahn, KW, Estrada-Merly, N, Alkhateeb, HB, Bal, S, Kharfan-Dabaja, MA, Dholaria, B, Foss, F, Gowda, L, Jagadeesh, D, Sauter, C, Abid, MB, Aljurf, M, Awan, FT, Bacher, U, Badawy, SM, Battiwalla, M, Bredeson, C, Cerny, J, Chhabra, S, Deol, A, Diaz, MA, Farhadfar, N, Freytes, C, Gajewski, J, Gandhi, MJ, Ganguly, S, Grunwald, MR, Halter, J, Hashmi, S, Hildebrandt, GC, Inamoto, Y, Jimenez-Jimenez, AM, Kalaycio, M, Kamble, R, Krem, MM, Lazarus, HM, Lazaryan, A, Maakaron, J, Munshi, PN, Munker, R, Nazha, A, Nishihori, T, Oluwole, OO, Ortí, G, Pan, DC, Patel, SS, Pawarode, A, Rizzieri, D, Saba, NS, Savani, B, Seo, S, Ustun, C, van der Poel, M, Verdonck, LF, Wagner, JL, Wirk, B, Oran, B, Nakamura, R, Scott, B & Saber, W 2022, , Transplantation and Cellular Therapy, vol. 28, no. 4, pp. 187.e1-187.e10. https://doi.org/10.1016/j.jtct.2022.01.017

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
Shadman, M, Pasquini, M, Ahn, KW, Chen, Y, Turtle, CJ, Hematti, P, Cohen, JB, Khimani, F, Ganguly, S, Merryman, RW, Yared, JA, Locke, FL, Ahmed, N, Munshi, PN, Beitinjaneh, A, Reagan, PM, Herrera, AF, Sauter, CS, Kharfan-Dabaja, MA & Hamadani, M 2022, , Blood, vol. 139, no. 9, pp. 1330-1339. https://doi.org/10.1182/blood.2021013289

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Menghrajani, K, Gomez-Arteaga, A, Madero-Marroquin, R, Zhang, MJ, Bo-Subait, K, Sanchez, J, Wang, HL, Aljurf, M, Assal, A, Bacher, VU, Badawy, SM, Bejanyan, N, Bhatt, VR, Bredeson, C, Byrne, M, Castillo, P, Cerny, J, Chhabra, S, Ciurea, SO, DeFilipp, Z, Farhadfar, N, Gadalla, S, Gale, RP, Ganguly, S, Gowda, L, Grunwald, MR, Hashmi, S, Hildebrandt, G, Kanakry, CG, Kansagra, A, Khimani, F, Krem, M, Lazarus, H, Liu, H, Martino, R, Michelis, FV, Nathan, S, Nishihori, T, Olsson, R, Reshef, R, Rizzieri, D, Rowe, JM, Savani, BN, Seo, S, Sharma, A, Solh, M, Ustun, C, Verdonck, LF, Hourigan, C, Sandmaier, B, Litzow, M, Kebriaei, P, Weisdorf, D, Zhang, Y, Tallman, MS & Saber, W 2022, , Blood Advances, vol. 6, no. 3, pp. 828-847. https://doi.org/10.1182/bloodadvances.2021004881

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
Wieduwilt, MJ, Metheny, L, Zhang, MJ, Wang, HL, Estrada-Merly, N, Marks, DI, Samer Al-Homsi, A, Muffly, L, Chao, N, Rizzieri, D, Gale, RP, Gadalla, SM, Cairo, M, Mussetti, A, Gore, S, Bhatt, VR, Patel, SS, Michelis, FV, Inamoto, Y, Badawy, SM, Copelan, E, Palmisiano, N, Kharfan-Dabaja, MA, Lazarus, HM, Ganguly, S, Bredeson, C, Perez, MAD, Cassaday, R, Savani, BN, Ballen, K, Martino, R, Wirk, B, Bacher, U, Aljurf, M, Bashey, A, Murthy, HS, Yared, JA, Aldoss, I, Farhadfar, N, Liu, H, Abdel-Azim, H, Waller, EK, Solh, M, Seftel, MD, van der Poel, M, Grunwald, MR, Liesveld, JL, Kamble, RT, McGuirk, J, Munker, R, Cahn, JY, Lee, JW, Freytes, CO, Krem, MM, Winestone, LE, Gergis, U, Nathan, S, Olsson, RF, Verdonck, LF, Sharma, A, Ringden, O, Friend, BD, Cerny, J, Choe, H, Chhabra, S, Nishihori, T, Seo, S, George, B, Baxter-Lowe, LA, Hildebrandt, GC, de Lima, M, Litzow, M, Kebriaei, P, Hourigan, CS, Abid, MB, Weisdorf, DJ & Saber, W 2022, , Blood Advances, vol. 6, no. 1, pp. 339-357. https://doi.org/10.1182/bloodadvances.2021004916

Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial
Bahlis, NJ, Siegel, DS, Schiller, GJ, Samaras, C, Sebag, M, Berdeja, J, Ganguly, S, Matous, J, Song, K, Seet, CS, Acosta-Rivera, M, Bar, M, Quick, D, Anz, B, Fonseca, G, Chung, W, Lee, K, Mouro, J, Agarwal, A & Reece, D 2022, , Leukemia and Lymphoma, vol. 63, no. 6, pp. 1407-1417. https://doi.org/10.1080/10428194.2022.2030477

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Murthy, GS, Kim, S, Hu, ZH, Estrada-Merly, N, Abid, MB, Aljurf, M, Bacher, U, Badawy, SM, Beitinjaneh, A, Bredeson, C, Cahn, JY, Cerny, J, Diaz Perez, MA, Farhadfar, N, Gale, RP, Ganguly, S, Gergis, U, Hildebrandt, GC, Grunwald, MR, Hashmi, S, Hossain, NM, Kalaycio, M, Kamble, RT, Kharfan-Dabaja, MA, Hamilton, BK, Lazarus, HM, Liesveld, J, Litzow, M, Marks, DI, Murthy, HS, Nathan, S, Nazha, A, Nishihori, T, Patel, SS, Pawarode, A, Rizzieri, D, Savani, B, Seo, S, Solh, M, Ustun, C, van der Poel, M, Verdonck, LF, Vij, R, Wirk, B, Oran, B, Nakamura, R, Scott, B & Saber, W 2022, , JAMA oncology, vol. 8, no. 3, pp. 404-411. https://doi.org/10.1001/jamaoncol.2021.6846

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
Balmaceda, N, Aziz, M, Chandrasekar, VT, McClune, B, Kambhampati, S, Shune, L, Abdallah, AO, Anwer, F, Majeed, A, Qazilbash, M, Ganguly, S, McGuirk, J & Mohyuddin, GR 2021, , BMC Cancer, vol. 21, no. 1, 730. https://doi.org/10.1186/s12885-021-08451-x

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults
Metheny, L, Callander, NS, Hall, AC, Zhang, MJ, Bo-Subait, K, Wang, HL, Agrawal, V, Al-Homsi, AS, Assal, A, Bacher, U, Beitinjaneh, A, Bejanyan, N, Bhatt, VR, Bredeson, C, Byrne, M, Cairo, M, Cerny, J, DeFilipp, Z, Perez, MAD, Freytes, CO, Ganguly, S, Grunwald, MR, Hashmi, S, Hildebrandt, GC, Inamoto, Y, Kanakry, CG, Kharfan-Dabaja, MA, Lazarus, HM, Lee, JW, Nathan, S, Nishihori, T, Olsson, RF, Ringdén, O, Rizzieri, D, Savani, BN, Savoie, ML, Seo, S, van der Poel, M, Verdonck, LF, Wagner, JL, Yared, JA, Hourigan, CS, Kebriaei, P, Litzow, M, Sandmaier, BM, Saber, W, Weisdorf, D & de Lima, M 2021, , Transplantation and Cellular Therapy, vol. 27, no. 11, pp. 923.e1-923.e12. https://doi.org/10.1016/j.jtct.2021.08.010

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States
Bhatt, NS, Brazauskas, R, Salit, RB, Syrjala, K, Bo-Subait, S, Tecca, H, Badawy, SM, Baker, KS, Beitinjaneh, A, Bejanyan, N, Byrne, M, Dias, A, Farhadfar, N, Freytes, CO, Ganguly, S, Hashmi, S, Hayashi, RJ, Hong, S, Inamoto, Y, Jamani, K, Kasow, KA, Khera, N, Krem, MM, Lazarus, HM, Lee, CJ, Lee, S, Majhail, NS, Malone, AK, Marks, DI, Mau, LW, Mayo, SJ, Muffly, LS, Nathan, S, Nishihori, T, Page, KM, Preussler, J, Rangarajan, HG, Rotz, SJ, Salooja, N, Savani, BN, Schears, R, Schechter-Finkelstein, T, Schiller, G, Shah, AJ, Sharma, A, Wang, T, Wirk, B, Battiwalla, M, Schoemans, H, Hamilton, B, Buchbinder, D, Phelan, R & Shaw, B 2021, , Transplantation and Cellular Therapy, vol. 27, no. 8, pp. 679.e1-679.e8. https://doi.org/10.1016/j.jtct.2021.04.013

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
Subbiah, V, Kuravi, S, Ganguly, S, Welch, DR, Vivian, CJ, Mushtaq, MU, Hegde, A, Iyer, S, Behrang, A, Ali, SM, Madison, RW, Venstrom, JM, Jensen, RA, McGuirk, JP, Amin, HM & Balusu, R 2021, , ESMO Open, vol. 6, no. 4, 100172. https://doi.org/10.1016/j.esmoop.2021.100172

Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation
Mulroney, CM, Bilal Abid, M, Bashey, A, Chemaly, RF, Ciurea, SO, Chen, M, Dandoy, CE, Diaz Perez, MA, Friend, BD, Fuchs, E, Ganguly, S, Goldsmith, SR, Kanakry, CG, Kim, S, Komanduri, KV, Krem, MM, Lazarus, HM, Ljungman, P, Maziarz, R, Nishihori, T, Patel, SS, Perales, MA, Romee, R, Singh, AK, Reid Wingard, J, Yared, J, Riches, M & Taplitz, R 2021, , British Journal of Haematology, vol. 194, no. 1, pp. 145-157. https://doi.org/10.1111/bjh.17563

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
CIBMTR Infection and Immune Reconstitution Working Committee 2021, , Blood, vol. 137, no. 23, pp. 3291-3305. https://doi.org/10.1182/blood.2020009362

Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy
Hoffmann, MS & Ganguly, S 2021, , Clinical Lymphoma, Myeloma and Leukemia, vol. 21, no. 6, pp. e548-e550. https://doi.org/10.1016/j.clml.2021.02.009

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation: N. Farhadfar et al
Farhadfar, N, Dias, A, Wang, T, Fretham, C, Chhabra, S, Murthy, HS, Broglie, L, DSouza, A, Gadalla, SM, Gale, RP, Hashmi, S, Al-Homsi, AS, Hildebrandt, GC, Hematti, P, Rizzieri, D, Chee, L, Lazarus, HM, Bredeson, C, Jaimes, EA, Beitinjaneh, A, Bashey, A, Prestidge, T, Krem, MM, Marks, DI, Benoit, S, Yared, JA, Nishihori, T, Olsson, RF, Freytes, CO, Stadtmauer, E, Savani, BN, Sorror, ML, Ganguly, S, Wingard, JR & Pasquini, M 2021, , Transplantation and Cellular Therapy, vol. 27, no. 5, pp. 410-422. https://doi.org/10.1016/j.jtct.2021.02.030

Preclinical evaluation of gilteritinib on NPM1-ALK-driven anaplastic large cell lymphoma cells
Kuravi, S, Cheng, J, Fangman, G, Polireddy, K, McCormick, S, Lin, TL, Singh, AK, Abhyankar, S, Ganguly, S, Welch, DR, Jensen, RA, McGuirk, JP & Balusu, R 2021, , Molecular Cancer Research, vol. 19, no. 5, pp. 913-920. https://doi.org/10.1158/1541-7786.MCR-20-0738

Correction: Allogeneic transplantation in elderly patients =65 years with non-Hodgkin lymphoma: a time-trend analysis (Blood Cancer Journal, (2019), 9, 12, (97), 10.1038/s41408-019-0261-1)
Shah, NN, Ahn, KW, Litovich, C, Sureda, A, Kharfan-Dabaja, MA, Awan, FT, Ganguly, S, Gergis, U, Inwards, D, Karmali, R, Lazaryan, A, Lekakis, L, Munshi, P, Nathan, S, Saad, AA, Solh, M, Steinberg, A, Vij, R, Wood, WA, Fenske, TS, Smith, S & Hamadani, M 2021, , Blood Cancer Journal, vol. 11, no. 4, 82. https://doi.org/10.1038/s41408-021-00472-w

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Kang, D, Ludwig, E, Jaworowicz, D, Huang, H, Fiedler-Kelly, J, Cortes, J, Ganguly, S, Khaled, S, Krämer, A, Levis, M, Martinelli, G, Perl, A, Russell, N, Abutarif, M, Choi, Y & Yin, O 2021, , Cancer Chemotherapy and Pharmacology, vol. 87, no. 4, pp. 513-523. https://doi.org/10.1007/s00280-020-04204-y

Peri-transplant extracorporeal photopheresis to mitigate GVHD- a pilot clinical trial
Abdelhakim, H, Accurso, A, Merkel, D, Dejarnette, S, Aljitawi, O, Yankee, T, He, J, Ganguly, S, McGuirk, J & Abhyankar, S 2021, , Bone Marrow Transplantation, vol. 56, no. 4, pp. 980-982. https://doi.org/10.1038/s41409-020-01142-4

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Hong, S, Brazauskas, R, Hebert, KM, Ganguly, S, Abdel-Azim, H, Diaz, MA, Beattie, S, Ciurea, SO, Szwajcer, D, Badawy, SM, Gratwohl, AA, LeMaistre, C, Aljurf, MDSM, Olsson, RF, Bhatt, NS, Farhadfar, N, Yared, JA, Yoshimi, A, Seo, S, Gergis, U, Beitinjaneh, AM, Sharma, A, Lazarus, H, Law, J, Ulrickson, M, Hashem, H, Schoemans, H, Cerny, J, Rizzieri, D, Savani, BN, Kamble, RT, Shaw, BE, Khera, N, Wood, WA, Hashmi, S, Hahn, T, Lee, SJ, Rizzo, JD, Majhail, NS & Saber, W 2021, , Cancer, vol. 127, no. 4, pp. 609-618. https://doi.org/10.1002/cncr.33232